The hypothesis was that mRNA and lncRNA expression in white blood cells from CML patients with BCR::ABL1 positive/negative expression could represent an BCR::ABL1 associated biomarker, linking for molecular pathways and preliminary data for further studies. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.